V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20055518 | 20133715 | 1.63 | null | null | 2016-08-27 | 2016-09-01 | CARBOPLATIN + PACLITAXEL + RT | N | null | CARBOPLATIN + PACLITAXEL + RT | 100695481 |
| 20055534 | 20133716 | 1.5 | null | null | 2019-04-18 | 2019-04-18 | CARBOPLATIN + PACLITAXEL + RT | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 100077497 |
| 20055561 | 20133717 | 1.75 | null | null | 2018-04-03 | 2018-04-17 | null | 01 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100594887 |
| 20055563 | 20133718 | 1.72 | 40 | Curative (C) | 2020-04-30 | 2020-05-19 | null | 02 | Y | CISPLATIN + ETOPOSIDE | 100485597 |
| 20055596 | 20133719 | null | null | Curative (C) | 2017-09-25 | 2017-10-10 | null | 02 | Y | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100095275 |
| 20055720 | 20133720 | 1.7 | null | null | 2019-09-02 | 2019-09-30 | null | 02 | null | MITOMYCIN INTRAVESICULAR | 100599059 |
| 20055747 | 20133721 | 1.76 | 0 | Neo-adjuvant (N) | 2017-11-13 | 2017-11-15 | null | 02 | Y | EVEROLIMUS | 101667755 |
| 20055857 | 20133722 | 1.8 | null | Palliative (P) | 2018-01-24 | 2018-01-24 | null | 02 | N | NOT MATCHED | 101013795 |
| 20056018 | 20133723 | 1.68 | 0 | null | 2016-12-20 | 2017-05-13 | null | 02 | N | CARBOPLATIN + FLUOROURACIL | 101740259 |
| 20056070 | 20133724 | 1.9 | 0 | Curative (C) | 2019-09-04 | 2019-09-04 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101046344 |
| 20056085 | 20133725 | 1.79 | 56.9 | Palliative (P) | 2018-12-22 | 2019-05-04 | Capecitabine + Cisplatin + RT | null | null | CAPECITABINE + CISPLATIN + RT | 101753787 |
| 20056134 | 20133726 | 1.7 | 121 | Palliative (P) | 2017-01-04 | 2017-09-10 | null | 02 | N | TRIFLURIDINE + TIPIRACIL | 100853781 |
| 20056284 | 20133727 | null | null | Curative (C) | 2018-08-27 | 2018-09-07 | null | 99 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101543009 |
| 20056344 | 20133728 | 1.78 | 72 | null | 2018-07-02 | 2018-10-28 | null | N | null | LENALIDOMIDE | 100972713 |
| 20056394 | 20133729 | 1.8 | 61.5 | Palliative (P) | 2018-04-20 | 2018-04-21 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 100508416 |
| 20056402 | 20133730 | 1.83 | 83.8 | null | 2018-03-10 | 2018-06-24 | null | 02 | null | ENZALUTAMIDE | 100058327 |
| 20056413 | 20133731 | 1.67 | 80.2 | null | 2016-10-05 | 2016-10-05 | null | N | null | MITOMYCIN INTRAVESICULAR | 101333285 |
| 20056426 | 20133732 | 1.8 | 60.4 | Palliative (P) | 2018-10-20 | 2020-02-27 | null | 02 | N | LENALIDOMIDE | 100635586 |
| 20056463 | 20133733 | 1.55 | 79.9 | null | 2018-04-24 | 2018-05-27 | null | N | null | LENALIDOMIDE | 100780128 |
| 20056524 | 20133734 | 1.69 | 71.5 | null | 2019-02-03 | 2019-02-07 | null | 02 | null | CISPLATIN | 100877608 |
| 20056578 | 20133735 | 0 | 59.2 | null | null | 2018-05-21 | null | null | null | OXALIPLATIN | 101797720 |
| 20056648 | 20133736 | 1.89 | 84.8 | null | 2017-02-10 | 2017-02-10 | BENDAMUSTINE + RITUXIMAB | 02 | N | COSMIC TRIAL | 101020777 |
| 20056722 | 20133737 | 0.9 | 81.9 | null | 2017-10-10 | 2017-10-11 | CAPECITABINE + LOMUSTINE | 02 | null | CEMIPLIMAB | 100796319 |
| 20056749 | 20133738 | 1.65 | 67.05 | Palliative (P) | 2018-06-24 | 2018-06-24 | null | 02 | N | ECF | 100567104 |
| 20056776 | 20133739 | 1.65 | null | Palliative (P) | 2019-08-12 | 2019-08-12 | Melphalan IV High dose | 02 | N | CISPLATIN + GEMCITABINE + RITUXIMAB | 101533361 |
| 20056828 | 20133740 | 1.75 | 80 | Palliative (P) | 2019-12-04 | 2019-12-04 | IBRUTINIB | 2 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100451694 |
| 20057123 | 20133742 | 1.75 | 68.6 | Neo-adjuvant (N) | 2019-04-06 | 2019-10-29 | Cyclophosphamide High Dose | 99 | Y | CHLORAMBUCIL | 100426505 |
| 20057164 | 20133743 | 1.53 | 97 | Palliative (P) | 2021-02-20 | 2021-03-28 | AFLIBERCEPT + FLUOROURACIL + IRINOTECAN | null | null | NEO-AEGIS TRIAL | 101859965 |
| 20057172 | 20133744 | 1.64 | 78 | null | 2022-03-10 | 2022-03-10 | TCH (21 day Trastuzumab) Maint | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100983615 |
| 20057274 | 20133745 | 1.86 | 92 | null | null | 2018-03-27 | CARBOPLATIN + FLUOROURACIL | 02 | N | RITUXIMAB | 101536904 |
| 20057611 | 20133747 | 1.73 | 81.5 | null | 2019-08-16 | 2019-08-17 | PHITT D Carboplatin / doxorubicin . | 02 | null | ATEZOLIZUMAB | 100150645 |
| 20057634 | 20133748 | 1.51 | 50.8 | Palliative (P) | 2020-05-24 | 2020-05-25 | CAPECITABINE + IRINOTECAN + Panitumumab | 02 | N | DOCETAXEL + NINTEDANIB | 100808277 |
| 20057665 | 20133750 | 1.66 | 64.4 | Palliative (P) | 2021-06-10 | 2021-06-29 | CHOP R - 21 days | 02 | N | AML17 TRIAL | 101358573 |
| 20057736 | 20133751 | 1.58 | 66.8 | null | 2022-05-30 | 2022-05-30 | Irinotecan + Raltitrexed | 02 | null | CISPLATIN + FLUOROURACIL + RT | 100898021 |
| 20057763 | 20133752 | 1.61 | null | Curative (C) | 2019-12-18 | 2020-01-18 | TRANSPLANT BEAM | 01 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100114769 |
| 20057775 | 20133753 | 1.83 | 37.9 | null | null | 2017-06-27 | Busulfan Oral | null | N | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 101763723 |
| 20057847 | 20133755 | 1.58 | 57.9 | 03 | 2014-03-28 | 2016-02-08 | Fluorouracil + Folinic + RT Bossett | Y | N | IPILIMUMAB + NIVOLUMAB | 101212682 |
| 20057877 | 20133756 | 1.61 | 100 | 03 | 2017-09-07 | 2019-08-01 | TEMOZOLOMIDE | Y | N | BENDAMUSTINE + RITUXIMAB | 100412468 |
| 20057908 | 20133757 | 1.64 | 78 | Neo-adjuvant (N) | null | 2019-01-27 | CAV | null | N | IRINOTECAN + MDG + PANITUMUMAB | 101845807 |
| 20057909 | 20133758 | null | null | Curative (C) | 2019-11-24 | 2020-02-18 | CISPLATIN + TEYSUNO | N | N | TEMOZOLOMIDE | 100725302 |
| 20058008 | 20133759 | 1.8 | 97.9 | Palliative (P) | 2018-06-14 | 2018-06-28 | KESTREL Trial | 02 | null | IBRUTINIB | 101637630 |
| 20058058 | 20133761 | 1.79 | 63 | Curative (C) | 2019-06-26 | 2019-07-12 | Carboplatin + Liposomal Doxorubicin | 02 | N | CAPECITABINE + LOMUSTINE | 100370115 |
| 20058138 | 20133763 | 1.87 | 70.7 | Palliative (P) | 2016-06-10 | 2016-06-10 | Doxorubicin 75mg/m2 | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101470208 |
| 20058150 | 20133764 | 1.79 | 74.5 | Disease modification (D) | 2016-09-30 | 2016-10-14 | PERTUZUMAB + TRASTUZUMAB | 02 | N | VENETOCLAX | 100008188 |
| 20058281 | 20133765 | 1.6 | 73.6 | null | 2019-03-20 | 2019-03-24 | SCOPE 2 TRIAL | 02 | N | EOF | 100139821 |
| 20058343 | 20133766 | 1.5 | 78.4 | Palliative (P) | 2020-04-13 | 2020-04-13 | Rituximab | Y | Y | CISPLATIN + TEYSUNO | 101471062 |
| 20058372 | 20133767 | 1.74 | 91.2 | Palliative (P) | 2019-03-17 | 2019-03-21 | CAV | 02 | N | CISPLATIN + DOCETAXEL | 100526255 |
| 20058587 | 20133770 | 1.69 | null | Palliative (P) | 2020-08-07 | 2020-08-07 | Pazopanib | 02 | null | ECARBOX | 101104895 |
| 20058761 | 20133771 | 1.75 | 88 | Palliative (P) | 2020-12-09 | 2020-12-09 | null | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100909921 |
| 20058800 | 20133772 | 1.53 | 77 | Palliative (P) | 2021-09-09 | 2021-09-09 | DARATUMUMAB | 02 | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100879685 |